Cash Flow Statement

Cash from Financing Activities Cash from Operations Change in Account Payables Change in Cash Change in Intangibles Change in Working Capital Exchange Rate Effect Free Cash Flow Gains from Investment Securities Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Income Sales of Property, Plant and Equipment

Daily Values

Growth Metrics

Others

Ratios

Innate Pharma (IPHA) Cash from Investing Activities (2019 - 2021)

Historic Cash from Investing Activities for Innate Pharma (IPHA) over the last 3 years, with Q4 2021 value amounting to -$1.0 million.